Skip to main content
High RiskFDAfda-F-0139-2021OTHER

Pacific Jade Indian Curry Sauce Starter With Fenugreek and Cardamom, wholesale case with 2, 39 oz. plastic tubs, case UPC 50758108742487

Category
Units Affected
153
Recall Date
October 27, 2020
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2021.

Product declared on shipping case does not match the inner packaged product. The inner packaged product contains Anchovy and anchovy is not an ingredient of the product identified on the shipping case.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Celtrade Canada or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2021.

CELTRADE CANADA

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Celtrade Canada Recall FAQ

Celtrade Canada is the subject of a food safety report: Pacific Jade Indian Curry Sauce Starter With Fenugreek and Cardamom, wholesale case with 2, 39 oz. plastic tubs, case UPC 50758108742487. The notice was published on October 27, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 153 units are potentially affected.